Article
1H-NMR metabolomics-based surrogates to impute common clinical risk factors and endpoints.
EBioMedicine · 2021 · EB. van den Akker, Bbmri-Nl, M. Beekman, D. Bizzarri, MJT. Reinders, PE. Slagboom
Key facts
| Title | 1H-NMR metabolomics-based surrogates to impute common clinical risk factors and endpoints. |
|---|---|
| First author | EB. van den Akker, Bbmri-Nl, M. Beekman, D. Bizzarri, MJT. Reinders, PE. Slagboom |
| Journal | EBioMedicine |
| Published | Dec 20, 2021 |
| DOI | 10.1016/j.ebiom.2021.103764 |
| PubMed ID | 34942446 |
| PMC ID | PMC8703237 |
| Devices mentioned | 103764 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1